{Reference Type}: Journal Article
{Title}: Curcumin nicotinate increases LDL cholesterol uptake in hepatocytes through IDOL/LDL-R pathway regulation.
{Author}: Huang Y;Liu FY;Yang JT;Zhao Q;Zhu MQ;Wang J;Long SY;Tuo QH;Zhang CP;Lin LM;Liao DF;
{Journal}: Eur J Pharmacol
{Volume}: 966
{Issue}: 0
{Year}: 2024 Mar 5
{Factor}: 5.195
{DOI}: 10.1016/j.ejphar.2024.176352
{Abstract}: <B>BACKGROUND: </B>Curcumin nicotinate (Curtn), derived from curcumin and niacin, reduces serum LDL-C levels, partly due to its influence on PCSK9. This study investigates IDOL's role in Curtn's lipid-lowering effects.<BR><B>OBJECTIVE: </B>To elucidate Curtn's regulation of the IDOL/LDLR pathway and potential molecular mechanisms in hepatocytes.<BR><B>METHODS: </B>Differential metabolites in Curtn-treated HepG2 cells were identified via LC-MS. Molecular docking assessed Curtn's affinity with IDOL. Cholesterol content and LDLR expression effects were studied in high-fat diet Wistar rats. In vitro evaluations determined Curtn's influence on IDOL overexpression's LDL-C uptake and LDLR expression in hepatocytes.<BR><B>RESULTS: </B>Lipids were the main differential metabolites in Curtn-treated HepG2 cells. Docking showed Curtn's higher affinity to IDOL's FERM domain compared to curcumin, suggesting potential competitive inhibition of IDOL's binding to LDLR. Curtn decreased liver cholesterol in Wistar rats and elevated LDLR expression. During in vitro experiments, Curtn significantly enhanced the effects of IDOL overexpression in HepG2 cells, leading to increased LDL-C uptake and elevated expression of LDL receptors.<BR><B>CONCLUSIONS: </B>Curtn modulates the IDOL/LDLR pathway, enhancing LDL cholesterol uptake in hepatocytes. Combined with its PCSK9 influence, Curtn emerges as a potential hyperlipidemia therapy.